ISTA Pharmaceuticals (ISTA) announces that it landed a U.S. patent allowance for Prolensa along...


ISTA Pharmaceuticals (ISTA) announces that it landed a U.S. patent allowance for Prolensa along with partner Senju Pharmaceuticals. The firm says it anticipates filing a New Drug Application with the FDA for Prolensa in H1, with a commercial launch expected in early 2013.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs